| |
 |
Nanotechnology
"The Next Stock Boom?" |
 |
"..Many industry
observers see nanotech as the next major driver of innovation,
the economy and the stock market, similar to the Internet of
the 1990s. "
-- Randall Lewis, CFA
Dear Reader:
We sometimes approach our analysts for
their thoughts on emerging market sectors we’re interested in.
On rarer occasions, they come to us with intriguing insights of
certain aspects of the market that have caught their attention.
At StockUpTicks, we’re technology buffs
so anything new and unusual catches our eye. The fact that they
think nanotechnology could very well change the way we live
and motivate the market simultaneously doesn’t hurt either.
Some are actually saying that nanotechnology could cause a market
boom reminiscent of the Internet stocks.
So, when Analyst Randy Lewis of EquityNet
Research, brought us his thoughts on nanotechnology, quite simply
defined as “The science of the very small” our interest was duly
piqued. As we read further into Randy’s short survey of this science
we became, how shall we say it, “enamored” with the prospects
of nanotechnology.
Now, being the ever-considerate distributors
of stock news and info that we endeavor to be, we felt it would
be best to get this in front of our info-thirsty readers. (That’s
you.)
Keep in mind, we are not recommending nanotechnology
stocks and have none planned as yet to put in front of you. This
is just strong commentary from a good analyst on a very intriguing
emerging science.
We think you’ll agree. Enjoy the piece
and stay tuned for two new stock stories slated for later this
week.
 |
Will
Nanotechnology Change the Way We Live? |
 |
According
to Mihail Roco, nanotech advisor to the White House,
"Because of nanotechnology, we’ll see more changes in the next
30 years than we saw in all the last century.”
By Randall Lewis, CFA
EquityNet Research
While the average investor might not know what nanotechnology
is, one thing is clear: it is big business. Nanotech has
already gained favor with a number of venture capital firms and
could likely be their darling this year too. Government
spending on research is expected to take a huge leap, and many
industry observers see nanotech as the next major driver of innovation,
the economy and the stock market, similar to the Internet of the
1990s. Government spending on nanotech began in 1998 with about
$115 million invested. Now, the Bush administration has
asked Congress to appropriate $679 million for 2003 to help the
U.S. catch up to technology development efforts of other countries
in this field. Already, European governments have spent
$164 million on nanotechnology in 2000; for 2002-2006 they have
allocated $1.2 billion.
Nanotechnology is an emerging technology that utilizes matter
at the scale of one-billionth of a meter (one nanometer), or 1/75,000th
the size of a human hair. Because there were no tools that existed
to allow scientists to observe, let alone manipulate, individual
atoms, nanotech did not emerge as an experimental science until
the early 1980s, with the invention by IBM researchers of new
microscopy techniques. It has been defined as the precision
placement, measurement, manipulation and modeling of sub-100 nanometer
scale matter, somewhere from 4 to 400 individual atoms.
The advantage of this technology is that at this level of matter,
laws of physics allow us to manipulate atoms, which combine to
form molecules, the building blocks of our natural world; this
allows scientists to produce new and better materials. In
other words, through the utilization of nanotechnology, we can
make new, artificial materials with predetermined properties.
The technology is already being used from sophisticated medical
purposes to simple household goods.
 |
Branches
of Nanotech |
 |
Though research and development and potential applications of
nanotech are extremely vast, it is typically segmented into five
markets: biological; instrumentation (the tool makers); physical
(better, faster products – such as computer hardware); materials
development; and futuristic (which includes advertising).
Although nanotech labs today focus primarily on basic research,
it is hoped that discoveries will soon apply to nearly all branches
of technology. It has been predicted that nanotech will lead to
new scientific advances, including mundane items such as scratch-proof
glass, precision drug delivery systems, and computers the size
of a sugar cube that could hold the entire Library of Congress.
Already, research points to revolutionary advances in materials,
pharmaceuticals and information technology.
Nanoscale approaches to computing: Molecular computing, which
uses single molecule switches to process data and quantum computing,
offers the potential that the speed of integrated circuits will
continue to double every 18 months, in accordance with Moore’s
Law. Already, using semiconductor nanotubes, researchers
have assembled several basic electronic components, including
transistors, the electronic logic gate at the heart of all computing.
Labs have also reported success with other nanomaterials, such
as silicon nanowires. This offers promise to the semiconductor
industry, which expects to hit the theoretical limit of photolithography
within a decade.
Biology and natural sciences: Other research groups are exploring
the intersection of nanotechnology and biology. Nanotechnology
offers the potential to recognize and control the bio-molecules
that govern normal as well as diseased cell activity. Implantable,
intracellular sensing systems, together with custom DNA chips
and smarter drugs hold the potential to transform biomedicine
into a much more precise discipline that it is today.
While these companies have no real product yet, their valuations
are skyrocketing commensurate with the perceived value that nanotech
will bring.
Given that the number of potential applications for nanotechnology
is far reaching, it is not surprising that there is significant
interest in this field. Future breakthroughs by nanotech
companies are likely to bring about more investor excitement regarding
the prospects of the industry as a whole and result in higher
valuations for the entire group. Some of the better-known companies
developing nanotechnology include General Electric (NYSE:GE),
Agilent Technologies (NYSE:A), IBM (NYSE:IBM), Hewlett-Packard
(NYSE:HWP), and Veeco Instruments (Nasdaq:VECO).
To be practical in the real world, nanotechnology must scale
up. Today researchers assemble nanodevices one molecule
at a time. However, to be useful, a device would have to
incorporate millions of molecules, precisely arranged. Researchers
are exploring this type of “self-assembly”. DNA has been
called the perfect example of a self-assembling machine: a single
molecule that, under the right conditions, creates not only replicas
of itself, but incredibly complex organisms.
With the caveats said, however, several facts remain clear.
First, the industry that is receiving a lot of attention, and
stocks in this arena are being afforded lofty valuations.
In fact, any company with “nano” in its name will receive a higher
valuation than a comparable firm that does not. But
fads often die hard; sales and earnings don’t. Many of these
highly valued stocks do not even have a marketable product; they
are simply functioning as research labs in the hopes of discovering
something innovative. Does “dot.com” ring a bell?
All in all however, most indicators point to the fact that nanotech
is a force to be reckoned with and could in fact change the way
we live. As the next wave of R&D is undertaken, it will
be interesting to see where in fact we end up and what glimpses
into the future we can garner.
 |
Randall
Lewis, CFA - EquityNet Research |
 |
Founder and Senior Equity Analyst of EquityNet, Randall Lewis
has more than 10 years experience in security and portfolio analysis,
as well as financial consulting and strategic planning.Prior to
forming EquityNet, Mr. Lewis was an account executive at Coffin
Communications Group, a Los Angeles-based financial communications
firm. Prior to this, Mr. Lewis served as an equity analyst at
SSI Investment Management, Inc., a $500-million, money management
firm, specializing in sophisticated, hedged investment strategies,
and serving institutional and high net worth clients. Previous
to SSI, Mr. Lewis was a financial analyst for Griffin Financial
Services, the securities brokerage arm of Home Savings of America,
the largest savings and loan in the U.S. As part of his experience,
Mr. Lewis has advised on strategic planning issues, facilitated
comprehensive financial analyses, and developed and published
financial reports, including business plans. Mr. Lewis has had
several articles published, most recently in HFR Journal of Hedge
Fund Research on the subject of merger arbitrage. Mr. Lewis received
his Bachelors Degree with honors in Finance from California State
University, Fullerton, and his MBA from the Anderson School of
Business at UCLA. He is also a holder of the Chartered Financial
Analyst (CFA) designation.
Visit EquityNet on the Web at: http://www.equitynet.net
 |
Contact
us: info@stockupticks.com |
 |
Want
to feature YOUR company to over 1 MILLION investors?
Click
here to
learn more about our programs or email us directly at info@stockupticks.com
Stockupticks
Safe Harbor Statement: Statements contained in this
document, including those pertaining to estimates and related
plans other than statements of historical fact, are forward-looking
statements subject to a number of uncertainties that could cause
actual results to differ materially from statements made.
Disclaimer:
StockUpTicks.com
is a property of Market Pathways Financial Relations Incorporated
(MP). The information, opinions and analysis contained herein
are based on sources believed to be reliable but no representation,
expressed or implied, is made as to its accuracy, completeness
or correctness. Past performance is no guarantee of future
results. This report is for information purposes only and should
not be used as the basis for any investment decision. MP
has not been compensated for distribution of this report.
Write or call MP for detailed disclosure as required by
Rule 17b of the Securities Act of 1933/1934. MP is not an
investment advisor and this report is not investment advice.
This information is neither a solicitation to buy nor an offer
to sell securities. Information contained herein contains
forward-looking statements and is subject to significant risks
and uncertainties, which will affect the results. The opinions
contained herein reflect our current judgment and are subject
to change without notice. MP and/or its affiliates, associates
and employees from time to time may have either a long or short
position in securities mentioned. Information contained
herein may not be reproduced in whole or in part without the express
written consent of Market Pathways Financial Relations Incorporated.
|
|